{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T04:58:45Z","timestamp":1781067525942,"version":"3.54.1"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100008990","name":"Science and Technology Department of Zhejiang Province","doi-asserted-by":"publisher","award":["YOPSI6bb66"],"award-info":[{"award-number":["YOPSI6bb66"]}],"id":[{"id":"10.13039\/501100008990","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004731","name":"Zhejiang Province Natural Science Foundation","doi-asserted-by":"publisher","award":["LQ24H310010"],"award-info":[{"award-number":["LQ24H310010"]}],"id":[{"id":"10.13039\/501100004731","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008092","name":"Jinhua City Science and Technology Bureau","doi-asserted-by":"publisher","award":["2021-3-044"],"award-info":[{"award-number":["2021-3-044"]}],"id":[{"id":"10.13039\/501100008092","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008092","name":"Jinhua City Science and Technology Bureau","doi-asserted-by":"publisher","award":["2024-3-046"],"award-info":[{"award-number":["2024-3-046"]}],"id":[{"id":"10.13039\/501100008092","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008092","name":"Jinhua City Science and Technology Bureau","doi-asserted-by":"publisher","award":["2023-3-069"],"award-info":[{"award-number":["2023-3-069"]}],"id":[{"id":"10.13039\/501100008092","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100017594","name":"Medical Science and Technology Project of Zhejiang Province","doi-asserted-by":"publisher","award":["2024KY1752"],"award-info":[{"award-number":["2024KY1752"]}],"id":[{"id":"10.13039\/501100017594","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100017594","name":"Medical Science and Technology Project of Zhejiang Province","doi-asserted-by":"publisher","award":["2025KY1743"],"award-info":[{"award-number":["2025KY1743"]}],"id":[{"id":"10.13039\/501100017594","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.bcp.2025.117562","type":"journal-article","created":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T15:57:38Z","timestamp":1764172658000},"page":"117562","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"P2","title":["Lysine methylation-mediated SMYD2 degradation by casticin sensitizes non-small-cell lung cancer cells to osimertinib therapy"],"prefix":"10.1016","volume":"243","author":[{"given":"Kailing","family":"Pan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Lou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianbo","family":"Xue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuehang","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingjing","family":"Dang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siyuan","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zan","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8922-1218","authenticated-orcid":false,"given":"Xianguo","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bcp.2025.117562_b0005","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.bcp.2025.117562_b0010","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1200\/JCO.2012.43.3912","article-title":"Epidermal growth factor receptor tyrosine kinase inhibitor-resistant disease","volume":"31","author":"Ohashi","year":"2013","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.bcp.2025.117562_b0015","doi-asserted-by":"crossref","first-page":"281","DOI":"10.3816\/CLC.2009.n.039","article-title":"Acquired resistance to epidermal growth factor receptor tyrosine kinase inhibitors in non-small-cell lung cancers dependent on the epidermal growth factor receptor pathway","volume":"10","author":"Nguyen","year":"2009","journal-title":"Clin. Lung Cancer"},{"key":"10.1016\/j.bcp.2025.117562_b0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2021.105998","article-title":"The natural product berberine synergizes with osimertinib preferentially against MET-amplified osimertinib-resistant lung cancer via direct MET inhibition","volume":"175","author":"Chen","year":"2022","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.bcp.2025.117562_b0025","article-title":"The root Extract of Scutellaria baicalensis Induces Apoptosis in EGFR TKI-Resistant Human Lung Cancer Cells by Inactivation of STAT3","volume":"22","author":"Park","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bcp.2025.117562_b0030","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.joim.2018.03.001","article-title":"Casticin from Vitex species: a short review on its anticancer and anti-inflammatory properties","volume":"16","author":"Chan","year":"2018","journal-title":"J. Integr. Med."},{"key":"10.1016\/j.bcp.2025.117562_b0035","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2023.1157558","article-title":"Casticin as potential anticancer agent: recent advancements in multi-mechanistic approaches","volume":"10","author":"Carbone","year":"2023","journal-title":"Front. Mol. Biosci."},{"key":"10.1016\/j.bcp.2025.117562_b0040","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.21873\/anticanres.13291","article-title":"Casticin Induces DNA damage and Impairs DNA Repair in Human Bladder Cancer TSGH-8301 Cells","volume":"39","author":"Huang","year":"2019","journal-title":"Anticancer Res"},{"key":"10.1016\/j.bcp.2025.117562_b0045","doi-asserted-by":"crossref","DOI":"10.1042\/BSR20180738","article-title":"Casticin inhibits breast cancer cell migration and invasion by down-regulation of PI3K\/Akt signaling pathway","volume":"38","author":"Fan","year":"2018","journal-title":"Biosci. Rep."},{"key":"10.1016\/j.bcp.2025.117562_b0050","doi-asserted-by":"crossref","first-page":"2461","DOI":"10.21873\/invivo.12061","article-title":"Casticin Inhibits In Vivo growth of Xenograft Tumors of Human Oral Cancer SCC-4 Cells","volume":"34","author":"Shang","year":"2020","journal-title":"In Vivo"},{"key":"10.1016\/j.bcp.2025.117562_b0055","doi-asserted-by":"crossref","DOI":"10.3390\/genes13050815","article-title":"Casticin Impacts Key Signaling Pathways in Colorectal Cancer Cells Leading to Cell Death with Therapeutic Implications","volume":"13","author":"Kowalski","year":"2022","journal-title":"Genes (Basel)"},{"key":"10.1016\/j.bcp.2025.117562_b0060","doi-asserted-by":"crossref","unstructured":"Fu, C., Zhang, K., Wang, M. & Qiu, F. Casticin and chrysosplenol D from Artemisia annua L. induce apoptosis by inhibiting topoisomerase II\u03b1 in human non-small-cell lung cancer cells. Phytomedicine 100, 154095, doi:10.1016\/j.phymed.2022.154095 (2022).","DOI":"10.1016\/j.phymed.2022.154095"},{"key":"10.1016\/j.bcp.2025.117562_b0065","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/9214130","article-title":"miR-338-3p Plays a significant Role in Casticin-Induced suppression of Acute Myeloid Leukemia via Targeting PI3K\/Akt Pathway","volume":"2022","author":"Yu","year":"2022","journal-title":"Biomed Res. Int."},{"key":"10.1016\/j.bcp.2025.117562_b0070","doi-asserted-by":"crossref","first-page":"10119","DOI":"10.1021\/acs.jmedchem.2c00325","article-title":"Protein Lysine Methyltransferase SMYD2: a Promising Small Molecule Target for Cancer Therapy","volume":"65","author":"Zheng","year":"2022","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bcp.2025.117562_b0075","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1038\/nature05287","article-title":"Repression of p53 activity by Smyd2-mediated methylation","volume":"444","author":"Huang","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.bcp.2025.117562_b0080","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.neo.2015.03.002","article-title":"Dysregulation of AKT Pathway by SMYD2-Mediated Lysine Methylation on PTEN","volume":"17","author":"Nakakido","year":"2015","journal-title":"Neoplasia"},{"key":"10.1016\/j.bcp.2025.117562_b0085","doi-asserted-by":"crossref","unstructured":"Tang, M. et al. SMYD2 inhibition-mediated hypomethylation of Ku70 contributes to impaired nonhomologous end joining repair and antitumor immunity. Sci. Adv. 9, eade6624, doi:10.1126\/sciadv.ade6624 (2023).","DOI":"10.1126\/sciadv.ade6624"},{"key":"10.1016\/j.bcp.2025.117562_b0090","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1038\/s41698-024-00557-2","article-title":"TP53 gain-of-function mutations promote osimertinib resistance via TNF-\u03b1-NF-\u03baB signaling in EGFR-mutated lung cancer","volume":"8","author":"Ibusuki","year":"2024","journal-title":"npj Precis. Oncol."},{"key":"10.1016\/j.bcp.2025.117562_b0095","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1038\/s41598-023-50568-5","article-title":"ITGB1 and DDR activation as novel mediators in acquired resistance to osimertinib and MEK inhibitors in EGFR-mutant NSCLC","volume":"14","author":"De Rosa","year":"2024","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bcp.2025.117562_b0100","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/s12943-018-0793-1","article-title":"EGFR-TKIs resistance via EGFR-independent signaling pathways","volume":"17","author":"Liu","year":"2018","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.bcp.2025.117562_b0105","doi-asserted-by":"crossref","first-page":"3256","DOI":"10.1158\/0008-5472.CAN-08-4055","article-title":"PTEN loss contributes to erlotinib resistance in EGFR-mutant lung cancer by activation of Akt and EGFR","volume":"69","author":"Sos","year":"2009","journal-title":"Cancer Res."},{"key":"10.1016\/j.bcp.2025.117562_b0110","doi-asserted-by":"crossref","first-page":"8377","DOI":"10.7150\/thno.37628","article-title":"Inhibition of SMYD2 suppresses tumor progression by down-regulating microRNA-125b and attenuates multi-drug resistance in renal cell carcinoma","volume":"9","author":"Yan","year":"2019","journal-title":"Theranostics"},{"key":"10.1016\/j.bcp.2025.117562_b0115","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10456-022-09839-4","article-title":"Targeting SMYD2 inhibits angiogenesis and increases the efficiency of apatinib by suppressing EGFL7 in colorectal cancer","volume":"26","author":"Zhang","year":"2023","journal-title":"Angiogenesis"},{"key":"10.1016\/j.bcp.2025.117562_b0120","doi-asserted-by":"crossref","first-page":"306","DOI":"10.3389\/fonc.2019.00306","article-title":"Inhibition of SMYD2 Sensitized Cisplatin to Resistant Cells in NSCLC through Activating p53 Pathway","volume":"9","author":"Shang","year":"2019","journal-title":"Front. Oncol."},{"key":"10.1016\/j.bcp.2025.117562_b0125","doi-asserted-by":"crossref","DOI":"10.3390\/molecules25061287","article-title":"An Overview of the potential Antineoplastic Effects of Casticin","volume":"25","author":"Ramchandani","year":"2020","journal-title":"Molecules"},{"key":"10.1016\/j.bcp.2025.117562_b0130","first-page":"21","article-title":"Genomic profiling in advanced stage non-small-cell lung cancer patients with platinum-based chemotherapy identifies germline variants with prognostic value in SMYD2","volume":"15","author":"Galv\u00e1n-Femen\u00eda","year":"2018","journal-title":"Cancer Treat. Res. Commun."},{"key":"10.1016\/j.bcp.2025.117562_b0135","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.ccell.2019.12.006","article-title":"Treatment-Induced tumor dormancy through YAP-mediated transcriptional reprogramming of the apoptotic pathway","volume":"37","author":"Kurppa","year":"2020","journal-title":"Cancer Cell"},{"key":"10.1016\/j.bcp.2025.117562_b0140","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1186\/s12935-019-1069-6","article-title":"Casticin inhibits nasopharyngeal carcinoma growth by targeting phosphoinositide 3-kinase","volume":"19","author":"Liu","year":"2019","journal-title":"Cancer Cell Int."},{"key":"10.1016\/j.bcp.2025.117562_b0145","article-title":"A Semi-Quantitative Drug Affinity Responsive Target Stability (DARTS) assay for studying Rapamycin\/mTOR interaction","author":"Zhang","year":"2019","journal-title":"J. Vis. Exp."},{"key":"10.1016\/j.bcp.2025.117562_b0150","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1038\/s41586-022-04431-8","article-title":"Low-dose metformin targets the lysosomal AMPK pathway through PEN2","volume":"603","author":"Ma","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.bcp.2025.117562_b0155","doi-asserted-by":"crossref","first-page":"D1197","DOI":"10.1093\/nar\/gkaa1063","article-title":"HERB: a high-throughput experiment- and reference-guided database of traditional Chinese medicine","volume":"49","author":"Fang","year":"2021","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.bcp.2025.117562_b0160","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/1476-4598-5-26","article-title":"Identification and characterization of Smyd2: a split SET\/MYND domain-containing histone H3 lysine 36-specific methyltransferase that interacts with the Sin3 histone deacetylase complex","volume":"5","author":"Brown","year":"2006","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.bcp.2025.117562_b0165","doi-asserted-by":"crossref","first-page":"2030","DOI":"10.1007\/s12031-022-02051-5","article-title":"STUB1-SMYD2 Axis Regulates Drug Resistance in Glioma cells","volume":"72","author":"Pan","year":"2022","journal-title":"J. Mol. Neurosci."},{"key":"10.1016\/j.bcp.2025.117562_b0170","doi-asserted-by":"crossref","DOI":"10.1136\/esmoopen-2016-000060","article-title":"Mechanisms of resistance to EGFR-targeted drugs: lung cancer","volume":"1","author":"Morgillo","year":"2016","journal-title":"ESMO Open"},{"key":"10.1016\/j.bcp.2025.117562_b0175","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1007\/s11655-022-3469-z","article-title":"Casticin attenuates stemness in cervical cancer stem-like cells by regulating activity and expression of DNMT1","volume":"29","author":"Wang","year":"2023","journal-title":"Chin. J. Integr. Med."},{"key":"10.1016\/j.bcp.2025.117562_b0180","doi-asserted-by":"crossref","DOI":"10.1016\/j.taap.2020.114998","article-title":"Casticin inhibits stemness of hepatocellular carcinoma cells via disrupting the reciprocal negative regulation between DNMT1 and miR-148a-3p","volume":"396","author":"Li","year":"2020","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.bcp.2025.117562_b0185","doi-asserted-by":"crossref","first-page":"19667","DOI":"10.1038\/s41598-021-99267-z","article-title":"Contribution of p53 in sensitivity to EGFR tyrosine kinase inhibitors in non-small cell lung cancer","volume":"11","author":"Jung","year":"2021","journal-title":"Sci. Rep."}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295225008275?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295225008275?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T04:21:53Z","timestamp":1781065313000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295225008275"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":37,"alternative-id":["S0006295225008275"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2025.117562","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Lysine methylation-mediated SMYD2 degradation by casticin sensitizes non-small-cell lung cancer cells to osimertinib therapy","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2025.117562","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"117562"}}